[AMBIZYGO: phase II study of high dose liposomal amphotericin B (AmBisome) [10 mg/kg/j] efficacy against zygomycosis].
Lanternier
F
F
Service de maladies infectieuses et tropicales, Centre d'infectiologie Necker Pasteur, Hôpital Necker Enfants malades, 149 rue de Sèvres, Paris, France. fanny.lanternier@nck.aphp.fr
Lortholary
O
O
D000666:Amphotericin B / Q000627:therapeutic use* / Q000633:toxicity*; D005260:Female; D006801:Humans; D008297:Male; D018579:Patient Selection; D016896:Treatment Outcome; D020096:Zygomycosis / Q000188:drug therapy*
C068538:liposomal amphotericin B; D000666:Amphotericin B